Key result
Developmental myosin mutations reduce step size and actin-detachment rate whereas β myosin R671C increases step size.
Why the study?
It was unknown whether homologous mutations in β, embryonic, and perinatal muscle myosins have similar molecular-level effects or correlate with disease phenotype and severity.
Homologous mutations in different myosin isoforms have divergent functional effects on molecular power generation, highlighting the highly allosteric nature of myosin.
Answers are grounded in this paper and cite their sources.
Animal data on myosin isoform divergence warrant caution in extrapolation; leaves open human disease relevance and isoform-targeted therapies.
Mutations at a highly conserved homologous residue in three closely related muscle myosins cause three distinct diseases involving muscle defects: R671C in β-cardiac myosin causes hypertrophic cardiomyopathy, R672C and R672H in embryonic skeletal myosin cause Freeman Sheldon syndrome, and R674Q in perinatal skeletal myosin causes trismus- pseudocamptodactyly syndrome. It is not known if their effects at the molecular level are similar to one another or correlate with disease phenotype and severity. To this end, we investigated the effects of the homologous mutations on key factors of molecular power production using recombinantly expressed human β, embryonic, and perinatal myosin subfragment-1. We found large effects in the developmental myosins, with the most dramatic in perinatal, but minimal effects in β myosin, and magnitude of changes correlated partially with clinical severity. The mutations in the developmental myosins dramatically decreased the step size and load-sensitive actin-detachment rate of single molecules measured by optical tweezers, in addition to decreasing ATPase cycle rate. In contrast, the only measured effect of R671C in β myosin was a larger step size. Our measurements of step size and bound times predicted velocities consistent with those measured in an in vitro motility assay. Finally, molecular dynamics simulations predicted that the arginine to cysteine mutation in embryonic, but not β, myosin may reduce pre-powerstroke lever arm priming and ADP pocket opening, providing a possible structural mechanism consistent with the experimental observations. This paper presents the first direct comparisons of homologous mutations in several different myosin isoforms, whose divergent functional effects are yet another testament to myosin’s highly allosteric nature.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied Hypertrophic cardiomyopathy, Freeman Sheldon syndrome, and trismus-pseudocamptodactyly syndrome. Homologous mutations in muscle myosins was evaluated on Molecular power production (step size, load-sensitive actin-detachment rate, ATPase cycle rate). Homologous mutations in developmental myosins dramatically decreased step size and actin-detachment rate, whereas the R671C mutation in β myosin only resulted in a larger step size.
Synapse has enriched 10 related papers. Consider them for comparative context: